{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/PFE/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-11-17T23:41:09.648Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":8278,"canonical_name":"PFIZER INC","cik":"0000078003","uei":null,"lei":null,"duns":null,"ticker":"PFE"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"clinical":65,"sec":18,"fda":3,"court":9},"count":95,"timeline":[{"ts":"2026-11-12","kind":"clinical.trial","reporter":"Pfizer","title":"The Purpose of This Study is to Learn About the Safety and Effectiveness of Berobenatide in Women With Urine Leakage and With Obesity or Overweight","security_title":"PHASE3","status":"NOT_YET_RECRUITING","accession_number":"NCT07932925","excerpt":"[\"Urinary Incontinence, Stress\",\"Overweight and/or Obesity\"]","importance":60},{"ts":"2026-11-12","kind":"sec.filing","form_type":"13F-HR","title":"13F-HR — PFIZER INC — 2026-11-12","url_slug":"/sec/cik-0000078003/13f-hr/0000078003-26-000135","accession_number":"0000078003-26-000135","importance":30},{"ts":"2026-11-12","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Study Medicine Called Prifetrastat in People With Renal Impairment","security_title":"PHASE1","status":"NOT_YET_RECRUITING","accession_number":"NCT07933848","excerpt":"[\"Renal Impairment\",\"Healthy Adults\"]","importance":30},{"ts":"2026-11-12","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn How Different Amounts of the Study Medicine Called PF-08166744 Are Tolerated and Act in Healthy Adults.","security_title":"PHASE1","status":"NOT_YET_RECRUITING","accession_number":"NCT07933835","excerpt":"[\"Healthy Participants\"]","importance":30},{"ts":"2026-11-09","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Assess the Safety of Marstacimab and How Well it Works in People With Mild to Moderate Hemophilia A or B Without Inhibitors","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT07923981","excerpt":"[\"Hemophilia A or B\"]","importance":60},{"ts":"2026-11-09","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About a Medicine (Called Elranatamab) in People With Relapsed Refractory Multiple Myeloma","security_title":null,"status":"NOT_YET_RECRUITING","accession_number":"NCT07927023","excerpt":"[\"Multiple Myeloma\"]","importance":25},{"ts":"2026-11-05","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About Study Medicine Called Berobenatide in Adults With Knee Pain and Overweight or Obesity (VESPER-OA 1)","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT07919678","excerpt":"[\"Obesity\",\"Overweight\",\"Osteoarthritis of the Knee\"]","importance":60},{"ts":"2026-11-04","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About Berobenatide Given Once Weekly in Adults With Knee Osteoarthritis and Overweight or Obesity With or Without Type 2 Diabetes (VESPER-OA 2)","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT07915609","excerpt":"[\"Obesity\",\"Overweight and/or Obesity\",\"Knee Osteoarthritis\",\"Diabetes Melliuts, Type 2\"]","importance":60},{"ts":"2026-11-03","kind":"sec.filing","form_type":"10-Q","title":"10-Q — PFIZER INC — 2026-11-03","url_slug":"/sec/cik-0000078003/10-q/0000078003-26-000127","accession_number":"0000078003-26-000127","importance":45},{"ts":"2026-11-03","kind":"sec.filing","form_type":"8-K","title":"8-K — PFIZER INC — 2026-11-03","url_slug":"/sec/cik-0000078003/8-k/0000078003-26-000125","accession_number":"0000078003-26-000125","importance":35},{"ts":"2026-11-03","kind":"sec.filing","form_type":"8-K","title":"8-K — PFIZER INC — 2026-11-03","url_slug":"/sec/cik-0000078003/8-k/0000078003-26-000132","accession_number":"0000078003-26-000132","importance":35},{"ts":"2026-11-02","kind":"clinical.trial","reporter":"Pfizer","title":"Real-World Treatment Patterns and Effectiveness of Anti-EGFR- and Anti-VEGF-based Therapies in Left-sided RAS Wild-Type Metastatic Colorectal Cancer","security_title":null,"status":"NOT_YET_RECRUITING","accession_number":"NCT07909122","excerpt":"[\"Metastatic Colorectal Cancer\"]","importance":25},{"ts":"2026-10-30","kind":"clinical.trial","reporter":"Pfizer","title":"Efficacy of Rimegepant 75 mg for the Acute Treatment of Migraine: a Bayesian Individual Participant Data Meta-analysis Standardized to Defined Target Populations","security_title":null,"status":"ACTIVE_NOT_RECRUITING","accession_number":"NCT07906262","excerpt":"[\"Migraine\"]","importance":25},{"ts":"2026-10-29","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Study Medicine Called PF-08098488 in People With Advanced Solid Tumors.","security_title":"PHASE1","status":"RECRUITING","accession_number":"NCT07903415","excerpt":"[\"Pancreatic Ductal Adenocarcinoma\",\"Esophageal Cancer\",\"Carcinoma, Non-Small-Cell Lung (NSCLC)\",\"Gastric Carcinoma\",\"Gastroesophageal Junction Adenocarcinoma\"]","importance":30},{"ts":"2026-10-28","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About COVID-19 Antivirals in People With SARS-CoV-2 Infection From 2023-2026","security_title":null,"status":"ACTIVE_NOT_RECRUITING","accession_number":"NCT07900139","excerpt":"[\"COVID-19 SARS-CoV-2 Infection\"]","importance":25},{"ts":"2026-10-27","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn How Different Amounts of the Study Medicine Called PF-08161842 Are Tolerated and Act in the Body in Healthy and Older Adults","security_title":"PHASE1","status":"NOT_YET_RECRUITING","accession_number":"NCT07897708","excerpt":"[\"Alzheimer Disease\"]","importance":30},{"ts":"2026-10-27","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Study Medicine Called PF-08165784 in People With PIK3CA-Mutated Advanced or Metastatic Solid Tumors","security_title":"PHASE1","status":"NOT_YET_RECRUITING","accession_number":"NCT07897721","excerpt":"[\"Advanced Breast Cancer\",\"Advanced or Metastatic Breast Cancer\",\"Metastatic Breast Cancer (HR+/ HER2-)\",\"Metastatic Colorectal Adenocarcinoma\"]","importance":30},{"ts":"2026-10-27","kind":"clinical.trial","reporter":"Pfizer","title":"A Real-world Study to Learn About of the Characteristics and Outcomes of Advanced or Metastatic Bladder Cancer Patients With Different Histologies","security_title":null,"status":"NOT_YET_RECRUITING","accession_number":"NCT07897669","excerpt":"[\"Metastatic Urothelial Carcinoma\",\"Urothelial Cancer\",\"Urothelial Carcinoma\",\"Locally Advanced or Metastatic Urothelial Carcinoma\",\"Bladder Cancer\",\"Bladder Neoplasms\",\"Bladder Tumors\",\"Cancer of Bladder\",\"Cancer of the Bladder\",\"Malignant Tumor of Urinary Bladder\",\"Neoplasms, Bladder\",\"Urinary Bladder Cancer\"]","importance":25},{"ts":"2026-10-22","kind":"clinical.trial","reporter":"Pfizer","title":"A Study of a Medicine Called Atirmociclib in Combination With Giredestrant in Adult Participants With ER-positive, HER2-negative Early-stage Breast Cancer","security_title":"PHASE3","status":"NOT_YET_RECRUITING","accession_number":"NCT07890597","excerpt":"[\"Early Breast Cancer\",\"Estrogen Receptor Positive (ER+), Human Epidermal Growth Factor Receptor 2 Negative (HER2-)\"]","importance":60},{"ts":"2026-10-21","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About Revaccination With a Vaccine Called RSVpreF in Older Adults","security_title":"PHASE3","status":"NOT_YET_RECRUITING","accession_number":"NCT07885956","excerpt":"[\"Respiratory Syncytial Virus (RSV)\"]","importance":60},{"ts":"2026-10-21","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Study Medicine Abrocitinib in People With Severe Atopic Dermatitis Who Have Switched From Other Therapies","security_title":null,"status":"NOT_YET_RECRUITING","accession_number":"NCT07887867","excerpt":"[\"Dermatitis, Atopic\"]","importance":25},{"ts":"2026-10-19","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Do Not Use a Breathing Machine (PAP) (VESPER-OSA 2)","security_title":"PHASE3","status":"NOT_YET_RECRUITING","accession_number":"NCT07881757","excerpt":"[\"Apnea\",\"Sleep Disorders\",\"Overweight and/or Obesity\"]","importance":60},{"ts":"2026-10-19","kind":"clinical.trial","reporter":"Pfizer","title":"A Phase IV Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma That is Not Responding to Four or More Standard Treatments or Has Come Back After Several Standard Treatments","security_title":"PHASE4","status":"NOT_YET_RECRUITING","accession_number":"NCT07881835","excerpt":"[\"Relapsed/Refractory Multiple Myeloma\",\"Multiple Myeloma\"]","importance":25},{"ts":"2026-10-15","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Study Medicine Called PF-08653944 Taken Once-Monthly Compared to Placebo in Chinese Adults With Overweight or Obesity","security_title":"PHASE3","status":"NOT_YET_RECRUITING","accession_number":"NCT07874633","excerpt":"[\"Obesity\",\"Overweight\"]","importance":60},{"ts":"2026-10-15","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn How Different Amounts of the Study Medicine Called PF-08656795 Are Tolerated and Act in Adults With Overweight or Obesity","security_title":"PHASE1","status":"NOT_YET_RECRUITING","accession_number":"NCT07876518","excerpt":"[\"Overweight and/or Obesity\"]","importance":30},{"ts":"2026-10-15","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn How Different Forms of the Study Medicine Called Berobenatide is Taken up Into the Blood in Adults With Overweight or Obesity","security_title":"PHASE1","status":"NOT_YET_RECRUITING","accession_number":"NCT07876531","excerpt":"[\"Overweight and/or Obesity\",\"Healthy Participants\"]","importance":30},{"ts":"2026-10-09","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Safety and Immune Responses of RSVpreF in Older Adults","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT07819097","excerpt":"[\"Adult\",\"Healthy Participants\"]","importance":60},{"ts":"2026-10-09","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Study Medicine Called Tilrekimig ( PF-07275315) in People With Severe Asthma","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT07869043","excerpt":"[\"Asthma\"]","importance":60},{"ts":"2026-10-08","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Use a Breathing Machine (PAP) (VESPER-OSA 1)","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT07823608","excerpt":"[\"Apnea\",\"Sleep Disorders\",\"Overweight and/or Obesity\"]","importance":60},{"ts":"2026-10-06","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Study Medicine Called Tilrekimig in People With Severe Asthma","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT07772921","excerpt":"[\"Asthma\"]","importance":60},{"ts":"2026-10-06","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe Eczema","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT07783425","excerpt":"[\"Atopic Dermatitis\"]","importance":60},{"ts":"2026-10-06","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Outcomes Between Study Medicines, Enzalutamide and Darolutamide Among Men With Metastatic Castration Sensitive Prostate Cancer (mCSPC)","security_title":null,"status":"ACTIVE_NOT_RECRUITING","accession_number":"NCT07779590","excerpt":"[\"Metastatic Castration Sensitive Prostate Cancer (mCSPC)\"]","importance":25},{"ts":"2026-10-05","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Study Medicine (Called Marstacimab) in People With Hemophilia A or B","security_title":null,"status":"NOT_YET_RECRUITING","accession_number":"NCT07859527","excerpt":"[\"Hemophilia\"]","importance":25},{"ts":"2026-10-01","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About a Medicine Called PF-08154225 in Participants With Autoimmune Diseases","security_title":"PHASE1,PHASE2","status":"NOT_YET_RECRUITING","accession_number":"NCT07782450","excerpt":"[\"Systemic Lupus Erythematosus\",\"Rheumatoid Arthritis\",\"Idiopathic Inflammatory Myositis\",\"Systemic Sclerosis\"]","importance":45},{"ts":"2026-10-01","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn How Different Forms of the Study Medicine Called PF-08049820 Are Absorbed and Eliminated in Healthy Adults","security_title":"PHASE1","status":"COMPLETED","accession_number":"NCT07597928","excerpt":"[\"Healthy Adults\",\"Healthy\"]","importance":30},{"ts":"2026-09-29","kind":"fda.recall","reporter":"Pfizer","title":"Class II","security_title":"Levoxyl (levothyroxine sodium tablets, USP), tablets, 175 mcg, 100 tablet bottle, Rx only, Distributed by Pfizer Inc., New York, NY 10017, Made in Austria.  NDC 60793-859-01.","excerpt":"Subpotent Drug: confirmed out-of-specification (OOS) assay during stability testing.","accession_number":"D-0052-2027","status":"Ongoing","product_type":"drug","importance":60},{"ts":"2026-09-29","kind":"fda.recall","reporter":"Pfizer","title":"Class II","security_title":"Levoxyl (levothyroxine sodium tablets, USP), tablets, 175 mcg, 1000-count bottle, Rx only,  Distributed by Pfizer Inc., New York, NY 10017, Made in Austria.  NDC 60793-859-10","excerpt":"Subpotent Drug: confirmed out-of-specification (OOS) assay during stability testing.","accession_number":"D-0051-2027","status":"Ongoing","product_type":"drug","importance":60},{"ts":"2026-09-29","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About Switching to a Monthly Study Medicine Called Berobenatide (PF-08653944) to Help Keep Weight Off in People With Overweight or Obesity","security_title":"PHASE3","status":"NOT_YET_RECRUITING","accession_number":"NCT07845500","excerpt":"[\"Obesity\",\"Overweight and/or Obesity\",\"Overweight\",\"Treatment Of Obesity\"]","importance":60},{"ts":"2026-09-29","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Study Medicine Called PF-08653944 in Otherwise Healthy Chinese Adults With Overweight or Obesity","security_title":"PHASE1","status":"NOT_YET_RECRUITING","accession_number":"NCT07845513","excerpt":"[\"Overweight\",\"Obesity\",\"Healthy Adults\"]","importance":30},{"ts":"2026-09-28","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT07595549","excerpt":"[\"Obesity\",\"Overweight and/or Obesity\",\"Overweight\"]","importance":60},{"ts":"2026-09-25","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Study Medicine Called Rimegepant in Adults When Used for the Prevention of Chronic Migraine","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT07729462","excerpt":"[\"Preventive Treatment of Migraine\"]","importance":60},{"ts":"2026-09-25","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About Revaccination With a Vaccine Called RSVpreF in Immunocompromised Adults","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT07768345","excerpt":"[\"Respiratory Syncytial Virus (RSV)\"]","importance":60},{"ts":"2026-09-25","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Study Medicine Called PF-08653944 Taken Once-Weekly Compared to Placebo in Chinese Adults With Overweight or Obesity","security_title":"PHASE3","status":"NOT_YET_RECRUITING","accession_number":"NCT07792954","excerpt":"[\"Obesity\",\"Overweight\"]","importance":60},{"ts":"2026-09-25","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About Safety and Effects of Once-monthly Treatment With Berobenatide in Adults With Obesity Disease in Japan (VESPER-JM)","security_title":"PHASE3","status":"NOT_YET_RECRUITING","accession_number":"NCT07794774","excerpt":"[\"Obesity\"]","importance":60},{"ts":"2026-09-25","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About Safety and Effects of Once-weekly Treatment With Berobenatide in Adults With Obesity Disease in Japan (VESPER-JW)","security_title":"PHASE3","status":"NOT_YET_RECRUITING","accession_number":"NCT07794761","excerpt":"[\"Obesity\"]","importance":60},{"ts":"2026-09-25","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Study Medicine Called Ponsegromab in Adults With Lung Cancer-Associated Significant Body Weight Loss","security_title":"PHASE1","status":"NOT_YET_RECRUITING","accession_number":"NCT07663630","excerpt":"[\"Non-small Cell Lung Cancer (NSCLC)\",\"Cachexia\"]","importance":30},{"ts":"2026-09-25","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Safety of Taking an Additional Dose of the Medicine Rimegepant in Adults With Migraine","security_title":"PHASE4","status":"RECRUITING","accession_number":"NCT07609914","excerpt":"[\"Acute Treatment of Migraine\"]","importance":25},{"ts":"2026-09-24","kind":"clinical.trial","reporter":"Pfizer","title":"A Phase 3 Study in India to Describe the Safety and Immunogenicity of RSVpreF","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT07653100","excerpt":"[\"Respiratory Syncytial Virus (RSV)\"]","importance":60},{"ts":"2026-09-24","kind":"clinical.trial","reporter":"Pfizer","title":"Study to Learn About a Respiratory Syncytial Virus Vaccine in Children at High Risk of RSV Disease","security_title":"PHASE3","status":"NOT_YET_RECRUITING","accession_number":"NCT07839871","excerpt":"[\"Respiratory Syncytial Virus (RSV)\"]","importance":60},{"ts":"2026-09-24","kind":"clinical.trial","reporter":"Pfizer","title":"A Continuation Study of Tilrekimig in Adults With Moderate-to-Severe Long-Term Breathing Difficulty, Known by the Medical Term of Chronic Obstructive Pulmonary Disease (COPD) to Learn About This Medicine When Used for a Long Period of Time","security_title":"PHASE3","status":"NOT_YET_RECRUITING","accession_number":"NCT07839884","excerpt":"[\"Moderate to Severe Chronic Obstructive Pulmonary Disease\"]","importance":60},{"ts":"2026-09-24","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Find Out if the Medicine Called Rimegepant is Safe for Adults in India","security_title":"PHASE4","status":"RECRUITING","accession_number":"NCT07685769","excerpt":"[\"Acute Treatment of Migraine\"]","importance":25},{"ts":"2026-09-23","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Assess the Safety, Tolerability, and Immunogenicity of 3 Lots of a Multivalent Pneumococcal Conjugate Vaccine Administered to Adults","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT07794748","excerpt":"[\"Pneumococcal Disease\"]","importance":60},{"ts":"2026-09-23","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn How Different Amounts of the Study Medicine Called PF-08642534 Are Tolerated and Act in the Body of People Who Have Obesity","security_title":"PHASE1","status":"RECRUITING","accession_number":"NCT07731139","excerpt":"[\"Obesity\"]","importance":30},{"ts":"2026-09-22","kind":"clinical.trial","reporter":"Pfizer","title":"Real-World Effectiveness of Ritlecitinib in Alopecia Areata Patients in the US: A Retrospective Analysis Using EHR and Claims Data","security_title":null,"status":"ACTIVE_NOT_RECRUITING","accession_number":"NCT07821216","excerpt":"[\"Alopecia Areata\"]","importance":25},{"ts":"2026-09-16","kind":"clinical.trial","reporter":"Pfizer","title":"Abrocitinib Treatment of Atopic Dermatitis in Children 2 to Less Than 6 Years of Age","security_title":"PHASE3","status":"NOT_YET_RECRUITING","accession_number":"NCT07823595","excerpt":"[\"Atopic Dermatitis\"]","importance":60},{"ts":"2026-09-10","kind":"clinical.trial","reporter":"Pfizer","title":"A Study in Young People and Adults to Learn About the Medicine Ritlecitinib for Treatment of Patchy Hair Loss, Known by the Medical Term as Moderate Alopecia Areata","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT07733765","excerpt":"[\"Alopecia Areata\"]","importance":60},{"ts":"2026-09-09","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn How the Study Medicine Called PF-08653945 is Taken up Into the Blood in Adults With Overweight or Obesity","security_title":"PHASE1","status":"RECRUITING","accession_number":"NCT07725809","excerpt":"[\"Overweight\",\"Obesity\",\"Healthy\"]","importance":30},{"ts":"2026-09-08","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT07629440","excerpt":"[\"Pneumococcal Disease\"]","importance":60},{"ts":"2026-09-04","kind":"fda.recall","reporter":"Pfizer","title":"Class II","security_title":"Dopamine HCl Inj., USP, 200 mg/5 mL (40 mg/mL), 5 mL Single-dose, 25 vials per tray, Rx only, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA, Vial NDC 0409-5820-11, Carton NDC 0409-5820-01.","excerpt":"Lack of Assurance of Sterility","accession_number":"D-0853-2026","status":"Ongoing","product_type":"drug","importance":60},{"ts":"2026-09-04","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT07765888","excerpt":"[\"Atopic Dermatitis\"]","importance":60},{"ts":"2026-09-04","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Compare the Blood Levels of Two Dosage Formulations of the Study Medicine in Healthy Adults","security_title":"PHASE1","status":"COMPLETED","accession_number":"NCT07594769","excerpt":"[\"Migraine\"]","importance":30},{"ts":"2026-09-04","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Single Dose Pharmacokinetics of Study Medicine Called Tilrekimig in Healthy Adults When Co-Mixed With rHuPH20","security_title":"PHASE1","status":"RECRUITING","accession_number":"NCT07792941","excerpt":"[\"Healthy\"]","importance":30},{"ts":"2026-09-02","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn How Different Amounts of the Study Medicine Called PF-08103402 Are Tolerated and Act in the Body in Healthy Adults or Adults With Mild To-moderate Asthma","security_title":"PHASE1","status":"RECRUITING","accession_number":"NCT07660731","excerpt":"[\"Healthy Volunteer Study\",\"Healthy Adults\",\"Healthy Participants\",\"Asthma\"]","importance":30},{"ts":"2026-08-31","kind":"clinical.trial","reporter":"Pfizer","title":"Study to Learn About Safety, Tolerability, and Immune Response of a Catch-up Pneumococcal Vaccine in Children and Adolescents","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT07660198","excerpt":"[\"Pneumococcal Disease\"]","importance":60},{"ts":"2026-08-31","kind":"sec.filing","form_type":"N-PX","title":"N-PX — PFIZER INC — 2026-08-31","url_slug":"/sec/cik-0000078003/n-px/0000078003-26-000111","accession_number":"0000078003-26-000111","importance":30},{"ts":"2026-08-28","kind":"clinical.trial","reporter":"Pfizer","title":"Tucatinib Continuation Study","security_title":"PHASE4","status":"NOT_YET_RECRUITING","accession_number":"NCT07768358","excerpt":"[\"HER2-positive Breast Cancer\",\"Cervical Cancer\",\"Biliary Tract Neoplasms\",\"Urothelial Cancer\",\"Advanced Non-Small Cell Lung Cancer\",\"Gastric or Gastroesophageal Junction Adenocarcinoma (GEC)\",\"Colorectal Cancer\"]","importance":25},{"ts":"2026-08-21","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn How the Study Medicine Called Atirmociclib is Handled by the Body in People With Normal Liver Function and Different Levels of Liver Disease","security_title":"PHASE1","status":"RECRUITING","accession_number":"NCT07677358","excerpt":"[\"Hepatic Impairment\",\"Healthy, Hepatic Insufficiency\",\"Healthy Adults\"]","importance":30},{"ts":"2026-08-20","kind":"clinical.trial","reporter":"Pfizer","title":"Real-World Effectiveness of RSV Vaccines Among Adults Using Target Trial Emulation in Epic Cosmos","security_title":null,"status":"ACTIVE_NOT_RECRUITING","accession_number":"NCT07673081","excerpt":"[\"Respiratory Syncytial Virus (RSV)\"]","importance":25},{"ts":"2026-08-17","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Safety of PENBRAYA During Pregnancy","security_title":null,"status":"RECRUITING","accession_number":"NCT07768163","excerpt":"[\"Meningococcal Disease\"]","importance":25},{"ts":"2026-08-13","kind":"sec.filing","form_type":"13F-HR","title":"13F-HR — PFIZER INC — 2026-08-13","url_slug":"/sec/cik-0000078003/13f-hr/0000078003-26-000102","accession_number":"0000078003-26-000102","importance":30},{"ts":"2026-08-12","kind":"sec.insider.p","reporter":"BOURLA ALBERT","title":"Chairman & CEO","shares":38000,"price_per_share":26.34,"usd_value":1000920,"security_title":"Common Stock","importance":51.00092},{"ts":"2026-08-10","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Evaluate 20vPnC in Healthy Chinese Infants","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT07754539","excerpt":"[\"Pneumococcal Diseases\"]","importance":60},{"ts":"2026-08-05","kind":"sec.insider.p","reporter":"BLAYLOCK RONALD E","title":null,"shares":39231,"price_per_share":25.46,"usd_value":998821,"security_title":"Common Stock","importance":50.99882126},{"ts":"2026-08-05","kind":"sec.insider.p","reporter":"Buckley Mortimer J","title":null,"shares":37632,"price_per_share":25.52,"usd_value":960369,"security_title":"Common Stock","importance":50.96036864},{"ts":"2026-08-05","kind":"sec.insider.s","reporter":"DAMICO JENNIFER B.","title":"SVP & Controller","shares":3278,"price_per_share":25.4,"usd_value":83261,"security_title":"Common Stock","importance":35.0832612},{"ts":"2026-08-04","kind":"sec.filing","form_type":"10-Q","title":"10-Q — PFIZER INC — 2026-08-04","url_slug":"/sec/cik-0000078003/10-q/0000078003-26-000095","accession_number":"0000078003-26-000095","importance":45},{"ts":"2026-08-04","kind":"sec.filing","form_type":"8-K","title":"8-K — PFIZER INC — 2026-08-04","url_slug":"/sec/cik-0000078003/8-k/0000078003-26-000094","accession_number":"0000078003-26-000094","importance":35},{"ts":"2026-07-28","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About How Food Affects the Uptake of Study Medicine Prifetrastat Into the Blood in Healthy Adults","security_title":"PHASE1","status":"NOT_YET_RECRUITING","accession_number":"NCT07731100","excerpt":"[\"Healthy Adults\"]","importance":30},{"ts":"2026-07-27","kind":"court.docket","reporter":"flnd","title":"GUEL v. PFIZER INC","security_title":"367 Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability","excerpt":"28:1332 Diversity-Product Liability","accession_number":"3:26-cv-04761","product_type":"Margaret Catharine Rodgers","importance":45},{"ts":"2026-07-23","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About How Different Forms of Study Medicine Prifetrastat Are Taken Up Into the Blood in Healthy Adults","security_title":"PHASE1","status":"RECRUITING","accession_number":"NCT07721402","excerpt":"[\"Healthy Participant\"]","importance":30},{"ts":"2026-07-01","kind":"sec.filing","form_type":"4","title":"4 — BOURLA ALBERT — 2026-07-01","url_slug":"/sec/cik-0001595703/4/0001225208-26-006273","accession_number":"0001225208-26-006273","importance":30},{"ts":"2026-06-26","kind":"court.docket","reporter":"flnd","title":"APPLEGATE v. PFIZER INC","security_title":"367 Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability","excerpt":"28:1332 Diversity-Product Liability","accession_number":"3:26-cv-04427","product_type":"Margaret Catharine Rodgers","importance":45},{"ts":"2026-06-24","kind":"court.docket","reporter":"flnd","title":"ADAMS WISE v. PFIZER INC","security_title":"367 Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability","excerpt":"28:1332 Diversity-Product Liability","accession_number":"3:26-cv-04390","product_type":"Margaret Catharine Rodgers","importance":45},{"ts":"2026-06-23","kind":"court.docket","reporter":"flnd","title":"WALKER v. PFIZER INC","security_title":"367 Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability","excerpt":"28:1332 Diversity-Product Liability","accession_number":"3:26-cv-04358","product_type":"Margaret Catharine Rodgers","importance":45},{"ts":"2026-06-19","kind":"court.docket","reporter":"flnd","title":"MOORE v. PFIZER INC","security_title":"367 Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability","excerpt":"28:1332 Diversity-Product Liability","accession_number":"3:26-cv-04320","product_type":"Margaret Catharine Rodgers","importance":45},{"ts":"2026-06-19","kind":"court.docket","reporter":"flnd","title":"DAVIS v. PFIZER INC","security_title":"367 Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability","excerpt":"28:1332 Diversity-Product Liability","accession_number":"3:26-cv-04321","product_type":"Margaret Catharine Rodgers","importance":45},{"ts":"2026-06-18","kind":"court.docket","reporter":"flnd","title":"SMITH v. PFIZER INC","security_title":"367 Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability","excerpt":"28:1332 Diversity-Product Liability","accession_number":"3:26-cv-04302","product_type":"Margaret Catharine Rodgers","importance":45},{"ts":"2026-06-18","kind":"sec.filing","form_type":"8-K","title":"8-K — PFIZER INC — 2026-06-18","url_slug":"/sec/cik-0000078003/8-k/0000078003-26-000085","accession_number":"0000078003-26-000085","importance":35},{"ts":"2026-06-18","kind":"sec.filing","form_type":"8-K","title":"8-K — PFIZER INC — 2026-06-18","url_slug":"/sec/cik-0000078003/8-k/0000078003-26-000087","accession_number":"0000078003-26-000087","importance":35},{"ts":"2026-06-16","kind":"sec.filing","form_type":"11-K","title":"11-K — PFIZER INC — 2026-06-16","url_slug":"/sec/cik-0000078003/11-k/0000078003-26-000078","accession_number":"0000078003-26-000078","importance":30},{"ts":"2026-06-16","kind":"sec.filing","form_type":"11-K","title":"11-K — PFIZER INC — 2026-06-16","url_slug":"/sec/cik-0000078003/11-k/0000078003-26-000080","accession_number":"0000078003-26-000080","importance":30},{"ts":"2026-06-09","kind":"court.docket","reporter":"flnd","title":"DANIELS v. PFIZER INC","security_title":"367 Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability","excerpt":"28:1332 Diversity-Product Liability","accession_number":"3:26-cv-04072","product_type":"Margaret Catharine Rodgers","importance":45},{"ts":"2026-06-09","kind":"sec.insider.s","reporter":"DAMICO JENNIFER B.","title":"SVP & Controller","shares":2000,"price_per_share":25.7,"usd_value":51400,"security_title":"Common Stock","importance":35.0514},{"ts":"2026-06-09","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn if the Study Medicine Called Fluconazole Changes How the Other Body Processes the Study Medicine PF-07248144","security_title":"PHASE1","status":"COMPLETED","accession_number":"NCT07636018","excerpt":"[\"Healthy Adults\"]","importance":30},{"ts":"2026-05-25","kind":"court.docket","reporter":"flnd","title":"DOLMAN v. PFIZER INC","security_title":"367 Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability","excerpt":"28:1332 Diversity-Product Liability","accession_number":"3:26-cv-03893","product_type":"Margaret Catharine Rodgers","importance":45}]}